Authors: VERGOTE I NEVEN P VANDERICK G VANDAM P VANBELLE Y DESUTTER P DEPRINS F DEMUYLDER X CLAERHOUT J CAMPO R ALBERTYN G

Citation: I. Vergote et al., TAMOXIFEN AND THE UTERUS, European journal of cancer, 34, 1998, pp. 1-3

Authors: TJALMA W VANMARCK E WEYLER J DIRIX L VANDAELE A GOOVAERTS G ALBERTYN G VANDAM P

Citation: W. Tjalma et al., QUANTIFICATION AND PROGNOSTIC RELEVANCE OF ANGIOGENIC PARAMETERS IN INVASIVE CERVICAL-CANCER, British Journal of Cancer, 78(2), 1998, pp. 170-174

Authors: TJALMA W DECUYPER E WEYLER J VANMARCK E DEPOOTER C ALBERTYN G VANDAM P

Citation: W. Tjalma et al., EXPRESSION OF BCL-2 IN INVASIVE AND IN-SITU CARCINOMA OF THE UTERINE CERVIX, American journal of obstetrics and gynecology, 178(1), 1998, pp. 113-117

Authors: TJALMA W WEYLER J VANDAELE A SONNEMANS H DEPOOTER C VANMARCK E ALBERTYN G VANDAM P

Citation: W. Tjalma et al., COMPUTERIZED ANALYSIS OF ANGIOGENESIS (CD31) IN INVASIVE CERVICAL-CARCINOMA - MULTIVARIATE-ANALYSIS, European journal of cancer, 33, 1997, pp. 213-213

Authors: VANLEUSDEN HAIM ALBERTYN G VERLAINE C VANRUYMBEKE J

Citation: Haim. Vanleusden et al., A COMPARATIVE MULTICENTER STUDY OF 2 TRANSDERMAL ESTRADIOL REPLACEMENT THERAPIES IN THE TREATMENT OF POSTMENOPAUSAL SYMPTOMS, International journal of fertility, 38(4), 1993, pp. 210-218